Emmanuelle Plaisier

Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up

Karine Dahan, Hanna Dêbiec, Emmanuelle Plaisier et al. · Journal of the American Society of Nephrology · 2016 · 403 citations · Full text

<i>COL4A1</i> Mutations and Hereditary Angiopathy, Nephropathy, Aneurysms, and Muscle Cramps

Emmanuelle Plaisier, Olivier Gribouval, Sonia Alamowitch et al. · New England Journal of Medicine · 2007 · 358 citations · Full text

<i>INF2</i>Mutations in Charcot–Marie–Tooth Disease with Glomerulopathy

Olivia Boyer, Fabien Névo, Emmanuelle Plaisier et al. · New England Journal of Medicine · 2011 · 281 citations · Full text

Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey

Benjamin Terrier, Evguenia Krastinova, I. Marie et al. · Blood · 2012 · 234 citations · Full text

The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy

Gema Fernández‐Juárez, Jorge Rojas-Rivera, Anne-Els van de Logt et al. · Kidney International · 2020 · 220 citations · Full text